Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Depreciation & Amortization (CF) (2020 - 2023)

Historic Depreciation & Amortization (CF) for ADC Therapeutics (ADCT) over the last 5 years, with Q4 2023 value amounting to $335000.0.

  • ADC Therapeutics' Depreciation & Amortization (CF) fell 6837.33% to $335000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.2 million, marking a year-over-year increase of 1198.11%. This contributed to the annual value of $1.3 million for FY2024, which is 1238.42% up from last year.
  • Per ADC Therapeutics' latest filing, its Depreciation & Amortization (CF) stood at $335000.0 for Q4 2023, which was down 6837.33% from $316000.0 recorded in Q3 2023.
  • ADC Therapeutics' 5-year Depreciation & Amortization (CF) high stood at $1.1 million for Q4 2022, and its period low was $88.0 during Q3 2019.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $258.5 (2022), whereas its average is $171133.1.
  • Per our database at Business Quant, ADC Therapeutics' Depreciation & Amortization (CF) crashed by 9988.24% in 2021 and then surged by 12579641.43% in 2023.
  • ADC Therapeutics' Depreciation & Amortization (CF) (Quarter) stood at $195.0 in 2019, then surged by 75797.44% to $148000.0 in 2020, then tumbled by 99.84% to $230.0 in 2021, then surged by 460435.65% to $1.1 million in 2022, then crashed by 68.37% to $335000.0 in 2023.
  • Its Depreciation & Amortization (CF) stands at $335000.0 for Q4 2023, versus $316000.0 for Q3 2023 and $273000.0 for Q2 2023.